Evaluation of the Role of XXXX as a Sclerosant in the Treatment of Primary Hydrocele.

@entity1 @entity13420
The present study was carried out with an aim to perform a prospective study to establish the role of @entity13420 (3  %) (STDS) as a safe and effective sclerosant in the management of primary hydrocele. Sclerotherapy was performed with 3  % STDS on an outdoor basis. The amount of sclerosant injected depended on the amount of fluid drained. All @entity1 were given prophylactic antibiotics. @entity1 were clinically reassessed at 1  week, 1  month, 3  months, and 6  months and earlier if complications occur. The data were analyzed using Statistical Package for Social Sciences Version 15.0. The data have been represented as frequencies and percentages. Chi-square test was used to compare the data. A total of 57 @entity1 with primary vaginal hydrocele gave consent for being enrolled in the study. The age of @entity1 ranged from 18 to 65  years with a mean age of 35.72        13.18  years. The success rate at the end of the study was observed to be 84.2  %. As regards @entity1 satisfaction, in present study, in a limited time period of follow up, all the @entity1 who had a successful procedure were satisfied. Overall, sclerotherapy was observed to be a relatively cost-effective (including both direct and indirect costs) procedure with low complications, high satisfaction, and a high success rate within the limited period of follow-up.
